EcoDrugPlus

Sodium- And Chloride-Dependent Gaba Transporter 1-Like

Ensembl ID : ENSSTUG00000008160
Gene Symbol: LOC115207211
3 Cross references
200 Possible Orthologues:

Sodium- And Chloride-Dependent Glycine Transporter 1-Like

Ensembl ID : ENSSTUG00000039623
Gene Symbol: LOC115157010
3 Cross references
202 Possible Orthologues:

Sodium- And Chloride-Dependent Glycine Transporter 1-Like

Ensembl ID : ENSSTUG00000013510
Gene Symbol: LOC115169760
3 Cross references
202 Possible Orthologues:

Sodium-Dependent Dopamine Transporter-Like

Ensembl ID : ENSSTUG00000025179
Gene Symbol: LOC115190613
3 Cross references
160 Possible Orthologues:

Sodium-Dependent Serotonin Transporter-Like

Ensembl ID : ENSSTUG00000034123
Gene Symbol: LOC115206062
3 Cross references
193 Possible Orthologues:

Sodium-Dependent Serotonin Transporter-Like

Ensembl ID : ENSSTUG00000017436
Gene Symbol: LOC115162800
3 Cross references
193 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSSTUG00000004061
Gene Symbol: LOC115204167
3 Cross references
244 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSSTUG00000008635
Gene Symbol: LOC115159468
3 Cross references
244 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-2

Ensembl ID : ENSSTUG00000033021
Gene Symbol: LOC115157489
3 Cross references
199 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-2-Like

Ensembl ID : ENSSTUG00000010539
Gene Symbol: LOC115169311
3 Cross references
199 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-2-Like

Ensembl ID : ENSSTUG00000030935
Gene Symbol: LOC115183252
3 Cross references
204 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-2-Like

Ensembl ID : ENSSTUG00000027404
Gene Symbol: LOC115154429
3 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).